{"id":"W2029549447","doi":"10.1016/j.jval.2011.02.887","title":"PCN29 TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) USING RITUXIMAB (R) WITH FLUDARABINE (F) AND CYCLOPHOSPHAMIDE (C): ASSESSING THE FINANCIAL IMPACT OF THE ROUTE OF ADMINISTRATION AT PRINCESS MARGARET HOSPITAL (PMH)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Roche (Canada)","funders":"","keywords":"Medicine; Fludarabine; Rituximab; Dosing; Cyclophosphamide; Route of administration; Regimen; Internal medicine; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001558276,0.000244811,0.0003959406,0.000285123,0.0002674662,0.0004799297,0.0004154839,0.000636066,0.002204414],"category_scores_gemma":[0.001908298,0.0001212695,0.0004865014,0.0002618338,0.0004350672,0.0004567879,0.000397901,0.0006550124,0.0002561082],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001269505,"about_ca_system_score_gemma":0.001235937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002244655,"about_ca_topic_score_gemma":0.004117924,"domain_scores_codex":[0.9990903,0.0006088332,0.00003646372,0.00005130868,0.0001284483,0.00008472086],"domain_scores_gemma":[0.999119,0.0002989821,0.0001878747,0.00003341185,0.00004886212,0.0003119733],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.3476222,0.02487865,0.1193571,0.0006922581,0.0008030044,0.001393045,0.0004753403,0.006542781,0.01591185,0.001088187,0.002324953,0.4789107],"study_design_scores_gemma":[0.0358405,0.6483464,0.2926127,0.0002277828,0.0006336914,0.001699014,0.0005073465,0.006952789,0.005123515,0.0004272895,0.007576591,0.00005237835],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978529,0.0007256803,0.0000551002,0.0001772281,0.00001123414,0.0001188248,0.00006554746,0.0000023776,0.0009911876],"genre_scores_gemma":[0.9988715,0.0003843865,0.0002170077,0.00007587274,0.00001599142,0.00005785061,0.0001089553,0.00000107927,0.0002674373],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002244655,"threshold_uncertainty_score":0.009210944,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04838158922218407,"score_gpt":0.3374780089602432,"score_spread":0.2890964197380592,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}